A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies

被引:60
作者
Chazenbalk, GD
Wang, Y
Guo, J
Hutchison, JS
Segal, D
Jaume, JC
McLachlan, SM
Rapoport, B
机构
[1] Cedars Sinai Res Inst, Autoimmune Dis Unit, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90048 USA
[3] Nichols Inst Diagnost, San Juan Capistrano, CA 92690 USA
[4] Vet Adm Med Ctr, San Francisco, CA 94121 USA
[5] Univ Calif San Francisco, San Francisco, CA 94121 USA
关键词
D O I
10.1210/jc.84.2.702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We used the secreted TSH receptor (TSHR) ectodomain variant TSHR-289 (truncated at amino acid residue 289 with a B-histidine tail) to investigate properties of TSHR autoantibodies in Graves' disease. Sequential concanavalin A and Ni-chelate chromatography extracted milligram quantities of TSHR-289 (similar to 20 -40% purity) from the culture medium. Nanogram quantities of this material neutralized the TSH binding inhibitory activity in all 15 Graves' sera studied. We generated a mouse monoclonal antibody (mAb), 3BD10, to partially purified TSHR-289. Screening of a TSHR complementary DNA fragment expression library localized the 3BD10 epitope to 27 amino acids at the N-terminus of the TSHR, a cysteine-rich segment predicted to be highly conformational. 3BD10 preferentially recognized native, as opposed to reduced and denatured, TSHR-289, but did not interact with the TSH holoreceptor on the cell surface, Moreover, mAb 3BD10 could extract from culture medium TSHR-289 nonreactive with autoantibodies, but not the lesser amount (similar to 25%) of TSHR-289 molecules capable of neutralizing autoantibodies. Although the active form of TSHR-289 in culture medium was stable at ambient temperature, stability was reduced at 37 C, explaining the mixture of active and inactive molecules in medium harvested from cell cultures. In conclusion, studies involving a TSHR ectodomain variant indicate the exquisite conformational requirements of TSHR autoantibodies. Even under "native" conditions, only a minority of molecules in highly potent TSHR-289 preparations neutralize patients' autoantibodies. Therefore, Graves' disease is likely to be caused by even lower concentrations of autoantibodies than previously thought. Finally, reciprocally exclusive binding to TSHR-289 by human autoantibodies and a mouse mAb with a defined epitope suggests that the extreme N-terminus of the TSHR is important for autoantibody recognition.
引用
收藏
页码:702 / 710
页数:9
相关论文
共 38 条
[1]  
BEEVER K, 1989, CLIN CHEM, V35, P1949
[2]   PHOTO-AFFINITY LABELING OF THE THYROTROPIN RECEPTOR [J].
BUCKLAND, PR ;
RICKARDS, CR ;
HOWELLS, RD ;
JONES, ED ;
SMITH, BR .
FEBS LETTERS, 1982, 145 (02) :245-249
[3]   Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites [J].
Chazenbalk, GD ;
Tanaka, K ;
Nagayama, Y ;
Kakinuma, A ;
Jaume, JC ;
McLachlan, SM ;
Rapoport, B .
ENDOCRINOLOGY, 1997, 138 (07) :2893-2899
[4]   Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells [J].
Chazenbalk, GD ;
Kakinuma, A ;
Jaume, JC ;
McLachlan, SM ;
Rapoport, B .
ENDOCRINOLOGY, 1996, 137 (11) :4586-4591
[5]   Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera [J].
Chazenbalk, GD ;
Jaume, JC ;
McLachlan, SM ;
Rapoport, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18959-18965
[6]   Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies [J].
Da Costa, CR ;
Johnstone, AP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11874-11880
[7]   VISUALIZATION OF THE THYROTROPIN RECEPTOR ON THE CELL-SURFACE BY POTENT AUTOANTIBODIES [J].
DEFORTEZA, R ;
SMITH, CU ;
AMIN, J ;
MCKENZIE, JM ;
ZAKARIJA, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1271-1273
[8]  
DORNER AJ, 1989, J BIOL CHEM, V264, P20602
[9]   EVIDENCE FOR THE HIGHLY CONFORMATIONAL NATURE OF THE EPITOPE(S) ON HUMAN THYROID PEROXIDASE THAT ARE RECOGNIZED BY SERA FROM PATIENTS WITH HASHIMOTOS-THYROIDITIS [J].
FINKE, R ;
SETO, P ;
RAPOPORT, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (01) :53-59
[10]   INTERACTION OF THYROTROPIN AND THYROID-STIMULATING ANTIBODIES WITH RECOMBINANT EXTRACELLULAR REGION OF HUMAN TSH RECEPTOR [J].
HARFST, E ;
JOHNSTONE, AP ;
NUSSEY, SS .
LANCET, 1992, 339 (8786) :193-194